S Brown

Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration

S Brown, Mark H. Greene, Sharon K. Gershon et al. · Arthritis & Rheumatism · 2002 · 661 citations

Life Sciences, Immunology, Pharmacotherapy +11

Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept

Jong‐Hoon Lee, Nancy R. Slifman, Sharon K. Gershon et al. · Arthritis & Rheumatism · 2002 · 448 citations

Medicine, Immunology, Pharmacotherapy +10

Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody.

Oliver W. Press, Janet F. Eary, C Badger et al. · Journal of Clinical Oncology · 1989 · 275 citations

Medicine, Nuclear Medicine, Oncology +16

Monoclonal anti-idiotype antibody therapy of B-cell lymphoma: the addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype-negative variant cells

DG Maloney, S Brown, DK Czerwinski et al. · Blood · 1992 · 83 citations · Full text

Medicine, Hematology, Oncology +14

Observations on the effect of chimeric anti-CD4 monoclonal antibody in patients with mycosis fungoides

SJ Knox, Ronald Levy, Suzanne Hodgkinson et al. · Blood · 1991 · 76 citations · Full text

Pharmacy, Immunology, Pathology +11